Debasmita Mukherjee*, Dr. Falguni Patra and Dr. Beduin Mahanti


Dengue fever, commonly known as break bone fever is a flu-like illness caused by the Dengue virus. Dengue, a vector born viral fever caused by the various stain of flavivirus and transmitted by female Aedes mosquitoes , remain a therapeutically challenging disease despite various antiviral drug (ribivirin, glycyrrhizin, and 6-aziridine)are under evaluation , its severity is more pronounced in immune -compromised patients , also presents with Dengue fever sequel as dengue hemorrhagic fever and Dengue hemorrhagic shock. Each serotype is sufficiently different that there is no cross- protection and epidemics caused by multiple serotypes can occur. However, several classes of agents are in under investigation as potential anti- dengue drugs, including direct host modulators, antiviral, and RNAi therapeutics. Dengue is caused by the Dengue virus (DENV). DENV is a single-stranded RNA positive -strand virus. The serotype is sufficiently different thet there is no cross-protection and epidemics caused by multiple serotypes can occur. The incidence of dengue has grown around the world in recent a period of ten years. Treatments, causes, anti dengue drugs in development will be reviewed here.

Keywords: Aedes Mosquito, Dengue Virus, Febrole, Epidemic, Serotype, Treatment, Homorrhagic, Vector, Flu.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tanima Debnath Sarkar

Download Article : Click here

News & Updation


    OCTOBER 2021 Issue has been successfully launched on 1 October 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction